Olympus Corp. Stock Hits Day Low Amid Price Pressure, Closes at JPY 1,818.50

Olympus Corp., a prominent player in the Pharmaceuticals & Biotechnology sector, experienced a notable decline of 3.68% on May 25, 2026, reaching an intraday low of JPY 1,818.50. This performance stands in contrast to the Japan Nikkei 225, which rose by 2.87% on the same day. Over the past week, Olympus Corp. has shown a positive trend with a gain of 4.27%, although this is overshadowed by the Nikkei's 7.14% increase. In the longer term, the stock has seen a 1-month performance of 18.97%, significantly outperforming the Nikkei's 9.11%. However, the year-to-date performance remains negative at -8.36%, while the Nikkei has gained 29.44%. Financial metrics indicate that Olympus Corp. has faced challenges, with a pre-tax profit of JPY 22,051 million reflecting a decline of 46.18%. The company's debt-equity ratio stands at a high 5.31%, and it has reported negative results for three consecutive quarters. Despite these hurdles, Olympus Corp. maintains a market capitalization of JPY 1,710,178 million and a P/E ratio of 18.00.